Guy Berchem

rue Thomas Edison, 1
1445 Luxembourg
Luxembourg

12179

Citations

Research activity per year

Fingerprint

Dive into the research topics where Guy Berchem is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Not started
17 Finished

BIILD: Integrative characterization of predictive, diagnostic, prognostic Biomarkers and Immune interactions involved in immune-related Interstitial Lung Diseases
Berchem, G. (PI) & Janji, B. (CoPI)
Project: Research
TRICK-ALDH: Assessment the impact of selective ALDH1 inhibitors on tumor infiltrating lymphocytes and the therapeutic benefit of Immune checkpoint blockers
Berchem, G. (PI), Janji, B. (CoPI) & Kumar, A. (Partner)
Advanced BioDesign
1/01/22 → 30/06/24
Project: Research
NCTCR: National Centre of Translational Cancer Research
Niclou, S. (PI) & Berchem, G. (CoPI)
FNR - Fonds National de la Recherche
1/01/22 → 31/12/22
Project: Research
Predi-COVID: Luxembourg cohort of positive patients for COVID-19: a stratification study to predict severe prognosis
Fagherazzi, G. (PI), Ollert, M. (CoPI), Berchem, G. (CoPI), Devaux, Y. (Partner), Hübschen, J. (Partner), Schlesser, M. (Partner) & Wilmes, P. (Partner)
FNR - Fonds National de la Recherche
1/04/20 → 31/03/22
Project: Research
CON-VINCE: COvid-19 National survey for assessing Viral spread by Non-affected Carriers
Krüger, R. (PI), Satagopam, V. P. (PI), Huiart, L. (CoPI), Ollert, M. (Partner), Berchem, G. (Partner), Betsou, F. (Partner), Brenner, D. (Partner), Gantenbein, M. (Partner), Vaillant, M. (Partner), Turner, J. (Partner), Aguayo, G. (Partner), Vaillant, M. (Partner), Bahlawane, C. (Partner), Roomp, K. (Partner), Hübschen, J. (Partner) & Snoeck, C. (Partner)
FNR - Fonds National de la Recherche
1/04/20 → 31/12/21
Project: Research

111 Article
19 Review article
7 Chapter
4 Comment/debate
More

Interpretable Machine Learning for Cross-Cohort Prediction of Motor Fluctuations in Parkinson's Disease
Krüger, R., Acharya, G., Aguayo, G., Alexandre, M., Batutu, R., Beaumont, K., Béchet, S., Berchem, G., Boussaad, I., Contesotto, G., Ferrari, A., Fritz, J., Gamio, C., Gantenbein, M., Georges, L., Giraitis, M., Graas, J., Hanff, A. M., Henry, E. & Henry, M. & 40 others, Hundt, A., Jónsdóttir, S., Klucken, J., Kofanova, O., Lambert, P., Landoulsi, Z., Lopes, A. F., Lorentz, V., Marques, T. M., Marques, G., Mcintyre, D., Mediouni, C., Mendibide, A., Menster, M., Mittelbronn, M., Mtimet, S., Munsch, M., Nehrbass, U., Nickels, S., Noor, F., Pauly, C., Pauly, L., Pavelka, L., Perquin, M., Pexaras, A., Rauschenberger, A., Remark, L., Richard, I., Roland, O., Sapienza, S., Sharify, A., Sokolowska, K., Theresine, M., Thien, H., Trouet, J., Tsurkalenko, O., Vaillant, M., Vega, C., Zelimkhanov, G. & the NCER-PD Consortium, Aug 2025, In: Movement Disorders. 40, 8, p. 1604-1617 14 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
1 Citation (Scopus)
Multi-cohort machine learning identifies predictors of cognitive impairment in Parkinson’s disease
Pavelka, L., Zelimkhanov, G., Vega, C., Vaillant, M., Tsurkalenko, O., Trouet, J., Thien, H., Theresine, M., Sokolowska, K., Sharify, A., Sapienza, S., Roland, O., Richard, I., Remark, L., Rauschenberger, A., Pexaras, A., Perquin, M., Pauly, L., Pauly, C. & Noor, F. & 43 others, Nickels, S., Nehrbass, U., Munsch, M., Mtimet, S., Mittelbronn, M., Menster, M., Mendibide, A., Mediouni, C., Mcintyre, D., Marques, G., Marques, T. M., Lorentz, V., Landoulsi, Z., Lambert, P., Krüger, R., Kofanova, O., Klucken, J., Jónsdóttir, S., Hundt, A., Henry, M., Henry, E., Hanff, A. M., Graas, J., Giraitis, M., Georges, L., Gantenbein, M., Gamio, C., Fritz, J., Lopes, A. F., Ferrari, A., De Bremaeker, N., Contesotto, G., Bouvier, D., Boussaad, I., Berchem, G., Béchet, S., Beaumont, K., Batutu, R., Alexandre, M., Aguayo, G., Acharya, G., NCER-PD Consortium & the ICEBERG study group, 26 Jul 2025, In: npj Digital Medicine. 8, 1, 12 p., 482.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
Penetrance of Parkinson’s disease in GBA1 carriers depends on variant severity and polygenic background
Landoulsi, Z., Zelimkhanov, G., Vega, C., Vaillant, M., Tsurkalenko, O., Trouet, J., Thien, H., Theresine, M., Sokolowska, K., Sharify, A., Sapienza, S., Roland, O., Richard, I., Remark, L., Rauschenberger, A., Pexaras, A., Perquin, M., Pavelka, L., Pauly, L. & Pauly, C. & 41 others, Noor, F., Nickels, S., Nehrbass, U., Munsch, M., Mtimet, S., Mittelbronn, M., Menster, M., Mendibide, A., Mediouni, C., Mcintyre, D., Marques, G., Marques, T. M., Lorentz, V., Lopes, A. F., Lambert, P., Kofanova, O., Klucken, J., Jónsdóttir, S., Hundt, A., Henry, M., Henry, E., Hanff, A. M., Graas, J., Giraitis, M., Georges, L., Gantenbein, M., Gamio, C., Fritz, J., Ferrari, A., De Bremaeker, N., Contesotto, G., Boussaad, I., Berchem, G., Béchet, S., Beaumont, K., Batutu, R., Alexandre, M., Aguayo, G., Acharya, G., Krüger, R. & NCER-PD Consortium, 12 Jun 2025, In: npj Parkinson's Disease. 11, 1, 8 p., 162.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
1 Citation (Scopus)
Targeting the atypical chemokine receptor 2 (Ackr2) improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model
Noman, M. Z., Szpakowska, M., Xiao, M., Gao, R., Van Moer, K., Kumar, A., Ollert, M., Berchem, G., Chevigné, A. & Janji, B., 18 Apr 2025, In: OncoImmunology. 14, 1, 9 p., 2494426.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
1 Citation (Scopus)
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients
El-Deiry, W. S., Bresson, C., Wunder, F., Carneiro, B. A., Dizon, D. S., Warner, J. L., Graff, S. L., Azzoli, C. G., Wong, E. T., Cheng, L., Mani, S. A., Safran, H. P., Williams, C., Meissner, T., Solomon, B., Rubin, E., Porgador, A., Berchem, G., Saintigny, P. & Onn, A. & 67 others, Bar, J., Berger, R., Gantenbein, M., Chen, Z., de Pádua Souza, C., Reis, R. M. V., Sekacheva, M., Cervantes, A., Dahut, W. L., Annunziata, C. M., Gober, K., Musallam, K. M., Al-Shamsi, H. O., Abu-Gheida, I., Salazar, R., Limaye, S., Aref, A. T., Reddel, R. R., Al Homsi, M. U., Rouf, A., Dermime, S., Al Suwaidi, J., Vlad, C., Buiga, R., Al Omari, A., Abdel-Razeq, H., Oñate-Ocaña, L. F., Nielsen, F. C., Graham, L., Rueter, J., Joshua, A. M., Girda, E., Libutti, S., Riedlinger, G., Salem, M. E., Farhangfar, C. J., Mesa, R. A., Faltas, B. M., Elemento, O., Pramesh, C. S., Sengar, M., Aoyama, S., Ikeda, S., Berindan-Neagoe, I., Gaddipati, H., Kulkarni, M., Auzias, E., Gerogianni, M., Wolikow, N., Istolainen, S., Schlafrig, P., Frankel, N. Z., Ferraro, A. R., Palma, J., Gimenez, A. P., Hernando-Calvo, A., Felip, E., Tsimberidou, A. M., Herbst, R. S., Tabernero, J., Schilsky, R. L., Liu, J., Lussier, Y., Raynaud, J., Batist, G., Magidi, S. & Kurzrock, R., 12 Mar 2025, In: Oncotarget. 16, 1, p. 140-162 23 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
3 Citations (Scopus)

Guy Berchem

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

BIILD: Integrative characterization of predictive, diagnostic, prognostic Biomarkers and Immune interactions involved in immune-related Interstitial Lung Diseases

TRICK-ALDH: Assessment the impact of selective ALDH1 inhibitors on tumor infiltrating lymphocytes and the therapeutic benefit of Immune checkpoint blockers

NCTCR: National Centre of Translational Cancer Research

Predi-COVID: Luxembourg cohort of positive patients for COVID-19: a stratification study to predict severe prognosis

CON-VINCE: COvid-19 National survey for assessing Viral spread by Non-affected Carriers

Interpretable Machine Learning for Cross-Cohort Prediction of Motor Fluctuations in Parkinson's Disease

Multi-cohort machine learning identifies predictors of cognitive impairment in Parkinson’s disease

Penetrance of Parkinson’s disease in GBA1 carriers depends on variant severity and polygenic background

Targeting the atypical chemokine receptor 2 (Ackr2) improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients

Guy Berchem

Fingerprint

Collaborations and top research areas from the last five years

Projects

Research output